Tgfbr1em1Yixi
Endonuclease-mediated Allele Detail
|
|
| Symbol: |
Tgfbr1em1Yixi |
| Name: |
transforming growth factor, beta receptor I; endonuclease-mediated mutation 1, Yichuan Xiao |
| MGI ID: |
MGI:7576933 |
| Synonyms: |
Tgfbr1K268R |
| Gene: |
Tgfbr1 Location: Chr4:47353258-47414926 bp, + strand Genetic Position: Chr4, 26.02 cM
|
| Alliance: |
Tgfbr1em1Yixi page
|
|
| Strain of Origin: |
Not Applicable
|
|
| Allele Type: |
|
Endonuclease-mediated (Not Applicable) |
| Mutation: |
|
Single point mutation
|
| |
|
Mutation details: Lysine codon 268 (AAA) in exon 4 was changed to arginine (AGA) (p.K268R) using an sgRNA and an ssODN template with CRISPR/Cas9 technology. The mutation blocks ubiquitination of the residue in the encoded peptide.
(J:343892)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Tgfbr1 Mutation: |
32 strains or lines available
|
|
| Original: |
J:343892 Pei S, et al., BFAR coordinates TGFbeta signaling to modulate Th9-mediated cancer immunotherapy. J Exp Med. 2021 Jul 5;218(7) |
| All: |
1 reference(s) |
|